Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02215408 · ClinicalTrials.gov registry record · NA
MEDication Focused Outpatient Care for Underutilization of Secondary Prevention
A NA study, sponsored by Korey Kennelty.
- Completed
- Registry status
- NA
- Development phase
- 402
- Enrollment target
NCT02215408: Completed NA study, sponsored by Korey Kennelty.
NCT02215408 is a NA study that has completed, run by Korey Kennelty. The registered enrollment target is 402 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02215408, a NA study, has completed, sponsored by Korey Kennelty.
- COMPLETED
- Registry status
- NA
- Development phase
- 402 participants
- Enrollment target
Study Summary
The study tested whether a pharmacist-run cardiovascular risk service (CVRS) at the University of Iowa can increase use of national standards of care in clinics
Primary Outcome
Of the 53 specific standards of care listed in the Guideline Advantage criteria, the mean percent of those standards applicable to each subject that are met at the 12 month time point
Interventions
- BEHAVIORAL CVRS Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 402 participants |
| Start Date | 2015-01-20 |
| Est. Completion | 2018-09-30 |
| Phase | NA |
What the finished NCT02215408 record still lists
NCT02215408 is an interventional study that assigns participants to a tested intervention. The registered 402 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 1 intervention - of which CVRS Intervention is the first listed.
NCT02215408 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02215408 about?
NCT02215408 is a clinical study titled "MEDication Focused Outpatient Care for Underutilization of Secondary Prevention". The study tested whether a pharmacist-run cardiovascular risk service (CVRS) at the University of Iowa can increase use of national standards of care in clinics
What is the current status of trial NCT02215408?
This trial is currently completed. It is a NA study. The enrollment target is 402 participants. The study started on 2015-01-20. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT02215408?
The interventions under investigation include: CVRS Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT02215408?
This trial is sponsored by Korey Kennelty, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02215408's enrollment target sits among peer trials
402 245th of 2000 higher than 1,755 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI